A Comparison of the <svg style="vertical-align:-0.216pt;width:15.0125px;" id="M1" height="10.725" version="1.1" viewBox="0 0 15.0125 10.725" width="15.0125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.725)">
		<g transform="translate(72,-63.42)">
			<text transform="matrix(1,0,0,-1,-71.95,63.68)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg>2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain

<table>The effects of (a) L-838,417and (b) TPA023 on chronic constriction injury-induced static allodynia in the rat. Data are <svg height="9.3249998" id="M22" style="vertical-align:-1.09097pt" version="1.1" viewbox="0 0 82.887497 9.3249998" width="82.887497" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,9.325)">
<g transform="translate(72,-64.54)">
<text transform="matrix(1,0,0,-1,-71.95,65.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">m</tspan>
<tspan style="font-size: 12.50px; " x="9.727334" y="0">e</tspan>
<tspan style="font-size: 12.50px; " x="15.278666" y="0">a</tspan>
<tspan style="font-size: 12.50px; " x="20.829998" y="0">n</tspan>
<tspan style="font-size: 12.50px; " x="27.081497" y="0">s</tspan>
</text>
<text transform="matrix(1,0,0,-1,-37.23,65.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">±</tspan>
</text>
<text transform="matrix(1,0,0,-1,-25.88,65.67)">
<tspan style="font-size: 12.50px; " x="0" y="0">s</tspan>
<tspan style="font-size: 12.50px; " x="4.863667" y="0">e</tspan>
<tspan style="font-size: 12.50px; " x="10.414999" y="0">m</tspan>
</text>
</g>
</g>
</svg>. <svg height="11.0375" id="M23" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 35.099998 11.0375" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">6</tspan>
</text>
</g>
</g>
</svg>. Data are expressed as 50% paw withdrawal threshold (PWT). BL: baseline. (<svg height="11.25" id="M24" style="vertical-align:-0.30096pt" version="1.1" viewbox="0 0 83.712502 11.25" width="83.712502" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.25)">
<g transform="translate(72,-63)">
<text transform="matrix(1,0,0,-1,-71.95,63.35)">
<tspan style="font-size: 12.50px; " x="0" y="0">∗</tspan>
<tspan style="font-size: 12.50px; " x="10.0024" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="22.042789" y="0">𝑃</tspan>
<tspan style="font-size: 12.50px; " x="32.945404" y="0">&lt;</tspan>
<tspan style="font-size: 12.50px; " x="44.985794" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="51.237293" y="0">.</tspan>
<tspan style="font-size: 12.50px; " x="54.363045" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="60.614544" y="0">5</tspan>
</text>
</g>
</g>
</svg>, ANOVA compared to vehicle-treated group). </table>

Advances in Pharmacological and Pharmaceutical Sciences

fig4

Figure 4

Figure 4: A Comparison of the <svg style="vertical-align:-0.216pt;width:15.0125px;" id="M1" height="10.725" version="1.1" viewBox="0 0 15.0125 10.725" width="15.0125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.725)">
		<g transform="translate(72,-63.42)">
			<text transform="matrix(1,0,0,-1,-71.95,63.68)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg>2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain 

Figure 4 | A Comparison of the 
	
		
			
				𝜶
			

		
	
2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain 

Advances in Pharmacological and Pharmaceutical Sciences

A Comparison of the 𝜶 2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain

Figure 4

A Comparison of the 2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain